What a Remarkable Journey!
Gyros Protein Technologies
Leading provider of peptide synthesis and bioanalytical tools for biotherapeutics, cell & gene therapies, and vaccines
From a few installations 20 years ago, Gyrolab is now found in bioanalytical and bioprocessing laboratories around the world and is recognized by our customers as a must-have technology.
Listen to the 2023 years webinar and learn how the Gyrolab platform is being used by our customers around the world to accelerate the development of cell and gene therapies.
Accelerating analysis of viral vector titer, process impurities, and contaminants
Learn from Meira GTx, Viralgen and VIVEbiotech how they are using the Gyrolab platform to accelerate viral titer, impurity and contaminant analysis in process development and quality control workflows.
Advancing Analytical Titer and Impurity Analysis with an Automated and Robust Immunoassay Platform
Learn how the Gyrolab® platform can advance analytical titers and contaminant analysis.
One-Step Separation of rAAV5 from Cell Lysate Using Magnetic Beads
Learn from Cytiva how they are using the Gyrolab platform for analytical analysis of viral titers and HCP in this case study evaluating the potential of using magnetic resins to separate rAAV5 up to 10 times faster compared to traditional state-of-the-art methods.
Development of anti-AAV assay for detection of pre-existing AAV immunity
Learn from Labcorp how they used the Gyrolab platform to develop an anti-AAV immunoassay to pre-screen individuals for pre-existing AAV immunity to maximize results in clinical/preclinical studies.
Recommended by LinkedIn
Challenges of developing ADA and concentration (PK or PD) assays for lysosomal transgene enzymes on an automated immunoassay platform
Learn from Resolian (formerly Alliance Pharma) how to overcome the challenges of developing and validating assays to monitor the concentration of expressed transgene lysosomal enzyme products and any associated immunogenicity.
Overcoming challenges in Preclinical Bioanalysis – sponsors, CROs and technology working together
Learn how Charles River Laboratories optimizes their use of Gyrolab platform for PK, anti-AAV ADA, and CSF ApoE biomarker assays to best serve the needs of sponsors.
Panel discussion: bioanalysis for the development and regulatory approval of cell and gene therapies
Join our expert panel, including representatives from QPS Holdings, Takeda Pharmaceuticals, and Gyros Protein Technologies, as they dissect current modalities and their unique analytical challenges, the platforms currently being used to facilitate cell and gene therapy development, and the primary regulatory challenges standing in the way of approval of such therapies.